Alan is the executive chairman at Symbio, joining the company in November 2023. With 35 years of experience in the pharmaceutical and clinical research industries, his background includes global leadership roles at prominent CROs and pharma companies. He also served as a non-executive board director at Gentronix and Algorics. Alan is passionate about delivering customer needs, bringing together the best people, system, and process with a collaborative, can-do culture and optimal organization design.
He holds an FCCA BS from City University London and is a Fellow of the Chartered Association of Certified Accountants (ACCA) in the UK.